← Back to Search

Intraocular Lens

Tecnis Eyhance for Pseudoaphakia

N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Surgical Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two types of artificial lenses used in cataract surgery, the TECNIS Eyhance IOL and the TECNIS 1-piece IOL. The TECNIS Eyhance IOL is a new lens designed to enhance intermediate vision, while the TECNIS 1-piece IOL is a standard lens. It targets patients who need lens implants in both eyes. The lenses help restore clear vision by replacing the cloudy natural lens with a clear one.

Eligible Conditions
  • Pseudoaphakia
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
MONOCULAR BEST-CORRECTED DISTANCE VISUAL ACUITY (BCDVA)
Secondary study objectives
MONOCULAR DISTANCE-CORRECTED INTERMEDIATE VISUAL ACUITY AT 66 CM (DCVA66)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Study LensExperimental Treatment1 Intervention
Tecnis Eyhance
Group II: Control LensActive Control1 Intervention
Tecnis 1 piece IOL (Intraocular lens)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tecnis Eyhance
2021
N/A
~230

Find a Location

Who is running the clinical trial?

Johnson & Johnson Surgical Vision, Inc.Lead Sponsor
36 Previous Clinical Trials
8,127 Total Patients Enrolled
Johnson & Johnson Surgical Vision Clinical TrialsStudy DirectorJohnson & Johnson Surgical Vision
17 Previous Clinical Trials
2,793 Total Patients Enrolled
~55 spots leftby Nov 2025